Download PDF
Thromb Haemost 1986; 55(02): 294-295
DOI: 10.1055/s-0038-1661541
Letter to the Editor
Schattauer GmbH Stuttgart

Heparin-Induced Thrombocytopenia and Pentosan Polysulfate: Treatment with a Low Molecular Weight Heparin Despite In Vitro Platelet Aggregation

J.-F Vitoux
*   Chaire de Clinique Medicale et de Pathologie Vasculaire Hôpital Broussais 96, rue Didot 75674 Paris Cé 14, France
,
M Roncato
**   Laboratoire d’Hemostase Hôpital Broussais 96, rue Didot 75674 Paris Céx 14, France
,
P Hourdebaigt
***   Service de Reanimation Medicale Polyvalente Hôpital Broussais 96, rue Didot 75674 Paris Céx 14, France
,
M Aiach
**   Laboratoire d’Hemostase Hôpital Broussais 96, rue Didot 75674 Paris Céx 14, France
,
J.-N Fiessinger
*   Chaire de Clinique Medicale et de Pathologie Vasculaire Hôpital Broussais 96, rue Didot 75674 Paris Cé 14, France
› Author Affiliations
Further Information

Publication History

Received 06 November 1985

Accepted 02 January 1986

Publication Date:
18 July 2018 (online)

  PDF Download  Permissions and Reprints
 

  • References

  • 1 Vitoux JF, Mathieu JF, Roncato M, Fiessinger JN, Aiach M. Heparin associated thrombocytopenia treatment with low molecular weight heparin. Thromb Haemostas 1986; 55: 37-39
    PubMedGoogle Scholar
  • 2 Sandler RM, Seifer DB, Morgan K, Pockros PJ, Wypych J, Weiss LM, Schiffman S. Heparin-induced thrombocytopenia and thrombosis: Detection and specificity of platelet aggregating IgG. Am J Clin Pathol 1985; 83: 760-764
    CrossrefPubMedGoogle Scholar
  • 3 Follea G, Mandrand B, Dechavanne M. Simultaneous enzy-moimmunologic assays of platelet associated IgG, IgM and C3. A useful tool in assessment of immune thrombocytopeniase. Thromb Res 1982; 26: 249-258
    CrossrefPubMedGoogle Scholar
  • 4 Kelton JG, Sheridan D, Brain H, Powers PJ, Turpie AG, Carter CJ. Clinical usefulness of testing for a heparin-depencjlent platelet-aggregating factor in patients with suspected heparin-associated thrombocytopenia. J Lab Clin Med 1984; 103: 606-612
    PubMedGoogle Scholar
  • 5 Boneu B, Sié P, Albarede JL, Bouloux C, Lansen J, Chigot C, Correlle S. Tolérance et activité pharmacologique du polysulphate de pentosane apres administration sous-cutanee et intra-musculaire pendant 10 jours. First International Symposium on Pentosan Polysulphate Paris 6th June: 1985
    Google Scholar
  • 6 Follea G, Hamandjian I, Trzeciak MC, Nedey Ch, Streichenberger R. Pentosan Polysulfate (SP 54) Induced Thrombocytopenia. Thromb Haemostas 1985 54. 94 (Abstr)
    PubMedGoogle Scholar
  • 7 Gouault-Heilmann M, Payen D, Contant G, Intrator L, Huet Y, Schaeffer A. Thrombocytopenia related to synthetic heparin analogue therapy. Thromb Haemostas 1985; 54: 557
    PubMedGoogle Scholar
  • 8 Maiza D, Derlon A, Khayat MC, Coulhon JP, Leporrier M. Role du polysulfate de pentosane dans le declenchement de deux accidents thrombopeniques. Presse Med 1985; 14: 1289-1290
    PubMedGoogle Scholar
  • 10 Gruel Y, Leroy J, Guerois C, Delahousse B, Briand T, Cibois D, Trouslard D. Thrombopenie et thrombose sous heparine. Necessite des tests d’agregation avant le traitement par l’heparine de bas poids moleculaire. Presse Med 1985; 14: 166
    PubMedGoogle Scholar